This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Amgen's Ilypsa subsidiary has spun-off Relypsa (polymeric therapeutics for renal and cardiovascular diseases). The company has raised $33mm through the closing of its Series A venture round. 5AM Ventures and New Leaf Venture Partners led the financing and were joined by the Sprout Group, Delphi Ventures, CMEA Ventures, and Mediphase Venture Partners.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?